Product Description
MOD GRF 1-29 Magnus Pharmaceuticals Peptide
MOD GRF 1-29 Magnus Pharmaceuticals Peptide (often simply referred to as Mod GRF) is an injectable peptide hormone to increase growth hormone production. This peptide is a growth hormone releasing hormone (GHRH) mimetic or analog. This means that it acts in the same way as GHRH and can be referred to as a GHRH. MOD GRF 1-29 Magnus Pharmaceuticals Peptide has a very anabolic effect.
Range of application of MOD GRF 1-29 Magnus Pharmaceuticals Peptide:
The main application area of MOD GRF 1-29 Magnus Pharmaceuticals Peptide consists of an increase in growth hormone levels. What also results in an increase in IGF-1 levels. An increase in these levels can help reduce the fat and, in some cases, the muscle build-up. In general, MOD GRF 1-29 Magnus Pharmaceuticals Peptide is used as part of an alternative plan for the use of growth hormones and is rarely combined with growth hormones.
The other primarily used GHRH product is CJC-1295. In almost all cases, I would prefer the use of MOD GRF 1-29 Magnus Pharmaceuticals Peptide using CJC-1295. The two products differ in terms of their duration of use. MOD GRF 1-29 Magnus Pharmaceuticals Peptide has an approximately ideal short duration of action, which allows a pulsatile dosage. While CJC-1295 has a significantly longer duration of action which makes such a dosage impossible.
In some cases, MOD GRF 1-29 Magnus Pharmaceuticals Peptide is marketed as a „CJC-1295 w / o DAC“. This is a confusing misnomer. If you see this label, you should simply interpret it as MOD GRF 1-29 Magnus Pharmaceuticals Peptide, because if a peptide does not have a DAC, it is not CJC-1295.
MOD GRF 1-29 Magnus Pharmaceuticals Peptide is generally not used alone but most frequently in combination with a peptide of the GHRP class such as GHRP-2, GHRP-6, hexareline or Ipamorelin.
The combination of MOD GRF 1-29 Magnus Pharmaceuticals Peptide with a GHRP:
MOD GRF 1-29 Magnus Pharmaceuticals Peptide shows its value best when it is used at the same time as a GHRP product rather than on its own. For any given amount of additional growth hormone production, less of a GHRP is needed when the GHRP is combined with Mod GRF. Or using the same amount of a GHRP, a greater increase in growth production could be achieved by combining with Mod GRF.
Examples of such a combination would be 100 mcg of MOD GRF 1-29 Magnus Pharmaceuticals Peptide injected at the same time as 100 mcg of GHRP-6 or Ipamorelin. Such a dosage will produce at least as much growth hormone distribution as 300 mcg of each of these products used alone.
The combination of MOD GRF 1-29 Magnus Pharmaceuticals Peptide and a GHRP is synergistic. The GHRP stimulates a pulse of growth hormone release and the Mod GRF amplifies this pulse.
When is MOD GRF 1-29 Magnus Pharmaceuticals Peptide used?
Whenever a moderately dosed growth hormone application cycle is considered, one could also consider a combination of MOD GRF 1-29 Magnus Pharmaceuticals Peptide and a GHRP as an alternative. Availability, cost, or personal preferences could be one reason for preferring a peptide stack. Another reason could be a personal preference, rather to stimulate the body‘s growth hormone production instead of replacing natural growth hormone production with injected growth hormones.
Reasons to consider the use of a peptide stack with MOD GRF 1-29 Magnus Pharmaceuticals Peptide may include increased fat loss, improved muscle growth when used in combination with anabolic steroids, cosmetic skin improvements, and improved wound healing.
MOD GRF 1-29 Magnus Pharmaceuticals Peptide Treatment:
MOD GRF 1-29 Magnus Pharmaceuticals Peptide does not have to be used cyclically. In general, it is more efficient to place its use at times during which an accelerated improvement in body composition or muscle mass is desired. MOD GRF 1-29 However, Magnus Pharmaceuticals can also be used consistently when the goal is a sustained increase in growth hormone levels. I recommend that the dosage of a MOD GRF 1-29 Magnus Pharmaceuticals Peptide Stacks should be at the lower end of the recommended range when used continuously. Alternatively, a full-strength dosage may be given, but only with one injection per day, which should be done shortly before bedtime.
Relatively rarely, undesirable side effects associated with excessive use of growth hormones during one MOD GRF 1-29 Magnus Pharmaceuticals Peptide application cycle may be associated with, inter alia, pain caused by nerve compression (such as carpal tunnel syndrome), excessive water storage, or reduced insulin sensitivity . The reason for this is the stimulation of a higher growth hormone production than is suitable for the individual case. The solution to this problem is to discontinue use until the problem is solved and reduce the dosage of the growth hormone-stimulating peptides when re-started to use.
How to Use MOD GRF 1-29 Magnus Pharmaceuticals Peptide:
MOD GRF 1-29 Magnus Pharmaceuticals Peptide is typically available in ampoules containing 2 mg of lyophilized powder, which may vary in amount. The contents of the ampoule are mixed with the desired amount of sterile or bacteriostatic water. When e.g. 2 ml of water are selected and the dosage of the ampoule is 2 mg, then the resulting solution has a concentration of 1 mg / ml or 1000 mcg / ml of MOD GRF 1-29 Magnus Pharmaceuticals Peptide.
Dosage MOD GRF 1-29 Magnus Pharmaceuticals Peptide:
At the time of dosing, a syringe is used to remove and inject the desired amount of MOD GRF 1-29 Magnus Pharmaceuticals Peptide from the ampoule. In the example above, a 100 mcg dose would correspond to a volume of 0.1 ml or the 10 IU label on a 100 IU / ml insulin syringe MOD GRF 1-29 Magnus Pharmaceuticals Peptide.
The injection may be subcutaneous, intramuscular or intravenous, depending on personal preference. If desired, a MOD GRF 1-29 Magnus Pharmaceuticals Peptide solution from another vial, e.g. Of a GHRP product with the same syringe. This reduces the total number of necessary injections.
I usually recommend a dose of 100 mcg of MOD GRF 1-29 Magnus Pharmaceuticals Peptide per injection in combination with a GHRP. For maximum effect, the injections should preferably be administered three times daily at times with low blood glucose levels, e.g. Before a meal. When used permanently, only one MOD GRF 1-29 Magnus Pharmaceuticals Peptide injection is administered each day before going to bed.
The pharmacological class of MOD GRF 1-29 Magnus Pharmaceuticals Peptide:
MOD GRF 1-29 Magnus Pharmaceuticals Peptide belongs to the class of Growth Hormone Releasing Hormone (GHRH) mimetics. GHRH is also the name of the naturally occurring hormone in the body, but the natural compound is not used in the field of bodybuilding or the sportive performance due to the high production costs and the extremely short duration of the action. MOD GRF 1-29 Magnus Pharmaceuticals Peptide is a modified version of the first 29 amino acids of GHRH, with the modification providing sufficient stability in the body for a useful short-term effect.
MOD GRF 1-29 Magnus Pharmaceuticals Peptide increases growth hormone production in the same way as GHRH, but administration does not initiate a pulse of growth hormone secretion. Only a MOD GRF 1-29 Magnus Pharmaceuticals Peptide injection is used to increase the growth hormone distribution only if the injection happened just before a pulse. If this is the case, the resulting pulse-like thrust of growth hormone release will be greater. If, however, there is no pulse of the growth hormone release at the time of the injection, then the Mod GRF has nothing to strengthen.
Factors that reduce the efficiency of a MOD GRF 1-29 Magnus Pharmaceuticals Peptide / GHRP Stacks:
A stack of MOD GRF 1-29 Magnus Pharmaceuticals Peptide and a GHRP will have reduced efficacy when the blood glucose levels are high at the time of injection when the thyroid hormone levels are low or when the IGF-1 levels are high as is the case, When injectable growth hormones are used in amounts as low as 14 IU per week or more (there is no black and white or a sharp dividing line here).
MOD GRF 1-29 Magnus Pharmaceuticals Peptide and the Sleep:
MOD GRF 1-29 used before falling asleep Magnus Pharmaceuticals can help with falling asleep and sometimes has the side effect of an increased vivacity of dreams. It is described in the scientific literature that the natural hormone GHRH also promotes sleep, which is why it is not surprising that this analogue causes it.
Conclusion MOD GRF 1-29 Magnus Pharmaceuticals Peptide:
When using a GHRP product, the addition of Mod GRF 1-29 can increase the resulting excitation of growth hormone production. Alternatively, MOD GRF 1-29 Magnus Pharmaceuticals Peptide may allow a lower dose of GHRP while at the same time achieving at least the same total growth hormone production. The dosage is typically 100 mcg per dose administered at the same time as administration of a GHRP product such as GHRP-2, GHRP-6, hexareline or ipamorelin.
